This is clear at the product level as well
In certain embodiments, the formulations or compositions comprise an excipient that decreases the release rate of the therapeutic agent
The study involved data from 16,827 patients evaluated by neuro-ophthalmologists, and focused on patients with type 2 diabetes or those who were overweight or obese, comparing those prescribed semaglutide to those using non-glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications
Sun W, Shahrajabian MH, Cheng Q
Weight Management As described above, berberine has shown some benefits in supporting weight management through the mechanisms described above, especially through its effects on increasing GLP-1 secretion and thereby improving insulin sensitivity and promoting feelings of satiety
McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM Jr